Recent publications
Prevalence of onchocerciasis and epilepsy in a Tanzanian region after a prolonged community-directed treatment with ivermectin.Mushi VP, Bhwana D, Massawe IS, Makunde W, Sebukoto H, Ngasa W, Sengerema J, Mhina A, Hayuma PM, Kimambo H, Kidima W, Matuja W, Sander JW, Cross H, Sen A, Colebunders R, Newton CR, Mmbando BP
PLoS Negl Trop Dis, (2024). 18:e0012470
Spatio-temporal distribution of rhinovirus types in Kenya: a retrospective analysis, 2014.Morobe JM, Kamau E, Luka MM, Murunga N, Lewa C, Mutunga M, Bigogo G, Otieno N, Nyawanda B, Onyango C, Nokes DJ, Agoti CN, Munywoki PK
Sci Rep, (2024). 14:22298
Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the PERCH study experience.Miyakawa R, Zhang H, Brooks WA, Prosperi C, Baggett HC, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Scott JAG, Thea DM, Antonio M, Awori JO, Bunthi C, Driscoll AJ, Ebruke B, Fancourt NS, Higdon MM, Karron RA, Moore DP, Morpeth SC, Mulindwa JM, Park DE, Rahman MZ, Rahman M, Salaudeen RA, Sawatwong P, Seidenberg P, Sow SO, Tapia MD, Knoll MD
Clin Microbiol Infect, (2024). S1198-743X:00505-6
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.Lucinde RK, Gathuri H, Isaaka L, Ogero M, Mumelo L, Kimego D, Mbevi G, Wanyama C, Otieno EO, Mwakio S, Saisi M, Isinde E, Oginga IN, Wachira A, Manuthu E, Kariuki H, Nyikuli J, Wekesa C, Otedo A, Bosire H, Okoth SB, Ongalo W, Mukabi D, Lusamba W, Muthui B, Adembesa I, Mithi C, Sood M, Ahmed N, Gituma B, Giabe M, Omondi C, Aman R, Amoth P, Kasera K, Were F, Nganga W, Berkley JA, Tsofa B, Mwangangi J, Bejon P, Barasa E, English M, Scott JAG, Akech S, Kagucia EW, Agweyu A, Etyang AO
BMC Infect Dis, (2024). 24:1246
Community-Based Health Information Systems in Africa: A Scoping Review of Data Generation, Utilization, and Community Empowerment.Kuvuna B, Nyanchoka M, Guleid F, Ogutu M, Tsofa B, Nzinga J
Wellcome Open Res, (2024). 9:485
Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial.Kamau Y, Tuwei M, Wanjiku C, Ominde K, Ngama M, Karisa J, Babu L, Muturi M, Mwatasa M, Adetifa J, Kern C, Duthaler U, Hammann F, Rabinovich R, Chaccour C, Maia MF
Int J Infect Dis, (2024). 148:107236
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.Gallagher KE, Lucinde R, Bottomley C, Kaniu M, Suaad B, Mutahi M, Mwalekwa L, Ragab S, Twi-Yeboah L, Berkley JA, Hamaluba M, Karani A, Shangala J, Otiende M, Gardiner E, Mugo D, Smith PG, Tabu C, Were F, Goldblatt D, Scott JAG
N Engl J Med, (2024). 391:2003-2013
Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.Connon R, Olupot-Olupot P, Pistorius AMA, Okiror W, Ssenyondo T, Muhindo R, Uyoga S, Mpoya A, Williams TN, Gibb DM, Walker AS, Ter Heine R, George EC, Maitland K
BMC Med, (2024). 22:516
Molecular xenomonitoring reveals Anopheles funestus and An.�rivulorum as the primary vectors of lymphatic filariasis in coastal Kenya.Bartilol B, Babu L, Garama K, Karisa J, Kamau A, Mwandawiro C, Wanjiku C, Mbogo C, Maia M, Mwangangi J, Rono MK
Parasit Vectors, (2024). 17:425
Caregiving experiences and practices: qualitative formative research towards development of integrated early childhood development interventions targeting Kenyans and refugees in Nairobi's informal settlements.Angwenyi V, Abubakar A, Kabue M, Njoroge E, Nasambu C, Ssewanyana D, Mulupi S, Marangu J, Ombech E, Mokaya MM, Obulemire EK, Zhang L, Moran G, Proulx K, Malti T, Martin MC, Lye S, Marfo K
BMC Public Health, (2024). 24:2636
ONT sequencing identifies a high prevalence of crt sensitive, triple mutant dhfr and single mutant dhps parasites within an ANC population in Nigeria.Adegbola AJ, Ndwiga L, Wamae K, Osoti V, Bolaji OO, Bejon P, Ochola-Oyier LI
Front Genet, (2024). 15:1470156
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.
Nat Neurosci, (2024). 27:1864-1879
Assessment of neonatal referral infrastructure and clinical characteristics of referred neonates in three first referral hospitals in Nairobi County, Kenya.Wainaina J, Irimu G, English M, Mbaire E, Waiyego M, Manyasi C, Kimutai D, Emadau C, Muturi C, Aluvaala J
Wellcome Open Res, (2023). 8:126
A cross-sectional analysis identifies a low prevalence of Plasmodium ovale�species �infections in symptomatic and asymptomatic individuals in Kilifi county, Kenya.Akinyi MY, Chifwete M, Ndwiga L, Kimenyi KM, Osoti V, Ochola-Oyier LI
Wellcome Open Res, (2022). 7:207
A mixed methods study examining the impact of primary health care financing transitions on facility functioning and service delivery in Kenya: a study protocol.Muthuri RNDK, Nzinga J, Tsofa B, Musiega A, Mugo P, Wong E, Mazzilli C, Ng'ang'a W, Hagedorn B, Turner G, Musuva A, Ravishankar N, Murira FM, Barasa E
Wellcome Open Res, (2024). 9:220
Examining the development and utilisation of Community-Based Health Information Systems (CBHIS) in Africa: A Scoping Review.Kuvuna B, Nyanchoka M, Guleid F, Ogutu M, Tsofa B, Nzinga J
Wellcome Open Res, (2024). 9:485
The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.Vasey MJ, Tai XY, Thorpe J, Jones GD, Ashby S, Hallab A, Ding D, Andraus M, Dugan P, Perucca P, Costello DJ, French JA, O'Brien TJ, Depondt C, Andrade DM, Sengupta R, Datta A, Delanty N, Jette N, Newton CR, Brodie MJ, Devinsky O, Cross JH, Sander JW, Hanna J, Besag FMC, Sen A
Epilepsia Open, (2024). 9:1931-1947
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.Schilling WHK, Mukaka M, Callery JJ, Llewelyn MJ, Cruz CV, Dhorda M, Ngernseng T, Waithira N, Ekkapongpisit M, Watson JA, Chandna A, Nelwan EJ, Hamers RL, Etyang A, Beg MA, Sow S, Yavo W, Allabi AC, Basnyat B, Sharma SK, Amofa-Sekyi M, Yonga P, Adler A, Yuentrakul P, Cope T, Thaipadungpanit J, Rienpradub P, Imwong M, Abdad MY, Blacksell SD, Tarning J, Goudjo FF, Dossou AD, Konat�-Tour� A, Assi SB, Ouffou� K, Nasronudin N, Rachman BE, Romadhon PZ, Dewanto DD, Heryana MO, Novi T, Pasaribu AP, Mutiara M, Nasution MPR, Khairunnisa K, Dalimunthe FA, Airlangga E, Fahrezzy A, Subronto Y, Ananda NR, Rahardjani M, Rimainar A, Lucinde RK, Timbwa M, Onyango OE, Agutu C, Akech S, Hamaluba M, Kipyego J, Ngachi O, Haidara FC, Traor� OY, Diarra F, Khanal B, Dahal P, Shrestha S, Rijal S, Kabore Y, Adehossi E, Guindo O, Qamar FN, Kazi AM, Woodrow CJ, Laird S, Cheeba M, Ayles H, Cheah PY, Taylor WRJ, Batty EM, Chotivanich K, Pukrittayakamee S, Phumratanaprapin W, von Seidlein L, Dondorp A, Day NPJ, White NJ
PLoS Med, (2024). 21:e1004428
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya.Nyiro JU, Nyawanda BO, Mutunga M, Murunga N, Nokes DJ, Bigogo G, Otieno NA, Lidechi S, Mazoya B, Jit M, Cohen C, Moyes J, Pecenka C, Baral R, Onyango C, Munywoki PK, Vodicka E
BMC Public Health, (2024). 24:2410
Prevalence of onchocerciasis and epilepsy in a Tanzanian region after a prolonged community-directed treatment with ivermectin.Mushi VP, Bhwana D, Massawe IS, Makunde W, Sebukoto H, Ngasa W, Sengerema J, Mhina A, Hayuma PM, Kimambo H, Kidima W, Matuja W, Sander JW, Cross H, Sen A, Colebunders R, Newton CR, Mmbando BP
PLoS Negl Trop Dis, (2024). 18:e0012470